Category: Oncotarget

Oncotarget News

Probiotic Bifidobacterium May Boost Cancer Treatment and Suppress Tumors

November 18, 2025

The anticancer properties of bifidobacterium may also stem from its ability to detoxify carcinogens and transform dietary elements.”BUFFALO, NY - November 18, 2025 – A new review was published in Oncotarget (... read more

Oncotarget

Clinical Trial Participants Call for More Inclusive, Patient-Centered Cancer Research

November 17, 2025

By embracing transparency, inclusivity, and patient advocacy, we can transform clinical trials into a true partnership between medical research and the individuals it seeks to serve.”BUFFALO, NY - November 17,... read more

Oncotarget

Lower LRIG1 Expression Linked to Aggressive Gliomas

November 12, 2025

Our results reinforce suggestions that LRIG1-3 could function as diagnostic markers and therapeutic targets in the treatment of gliomas.”BUFFALO, NY - November 12, 2025 – A new research paper was published... read more

Oncotarget

Eco-Friendly Nanoparticles Improve Cidofovir’s Anticancer and Antiviral Effects

November 10, 2025

This environmentally friendly technique represents a novel approach to nanoparticle fabrication, emphasizing sustainability in nanotechnology.”BUFFALO, NY - November 10, 2025 – A new research paper was published in Oncotarget (Volume... read more

Oncotarget

Folate Receptor Beta Found in Pediatric Tumors May Improve Fluorescence-Guided Cancer Surgery

October 20, 2025

This pre-clinical study demonstrates a broad potential application for pafolacianine in pediatric solid tumor resection.”BUFFALO, NY - October 20, 2025 – A new research paper was published in Volume 16 of... read more

Oncotarget

New Radiofrequency Therapy Slows Glioblastoma Growth and Targets Tumor Stem Cells

October 14, 2025

Intrabuccal administration of amplitude-modulated 27.12 MHz radiofrequency electromagnetic fields (AM RF EMF) resulting in the systemic delivery of low and safe levels of AM RF EMF has shown activity... read more